1. GBp

    1,364

    Today's change

    18.00 / +1.34%

    1 year change

    -12.20%

    As of Feb 12 2016 17:14 GMT. Data delayed by at least 15 minutes.

Search for GlaxoSmithKline PLC and
  1. February 12, 2016

    GSK fined £37m for stifling launch of rival drug Seroxat

    GlaxoSmithKline has been fined £37m for illegally stifling the launch of a cheap rival drug, marking the biggest...

  2. Fast FT

    February 12, 2016

    GlaxoSmithKline hit with £37m fine

    UK pharma company GlaxoSmithKline has been hit with a £37m fine by the Competition and Markets Authority for “illegal...

Special Reports

  1. Doing Business in China

    The relentless slowdown in the broader Chinese economy that has been under way for the...
  2. Japan: Technology & Innovation

    Among investors, Japan is often still seen as the spiritual home of the flabby conglom...
Search more Special Reports on this topic.

  1. February 8, 2016

    Sir Philip should beef up governance code to get women into top jobs

    “She is one of those managing females,” the head of a small company said recently and dismissively. Thankfully, he is...

  2. February 4, 2016

    Numbers games and existential angst

    Two down-at-heel figures loitered in a desolate landscape. It could have been Waiting for Godot, a play by Irish...

  3. Fast FT

    February 4, 2016

    Opening Quote: Shell protects divi, Compass ploughs on

    Shell’s profits have slumped with the oil price, AstraZeneca’s sales are stalling, the Bank of England is set to hold...

  4. FT Alphaville

    February 4, 2016

    FT Opening Quote

    Shell profits have slumped with the oil price, AstraZeneca sales are stalling, the Bank of England is set to hold...

  5. February 3, 2016

    GSK’s Witty avoids the City’s would-be surgeons

    Sir Andrew Witty, chief executive of GlaxoSmithKline, is having his yearly City health check up. Corporate doctor: What...

  6. February 3, 2016

    GlaxoSmithKline: stabilising

    A chart of GSK’s share price against the Stoxx Europe 600 Healthcare index during the past year shows an unfamiliar...

  7. February 3, 2016

    GlaxoSmithKline rules out break-up as new drugs boost sales

    GlaxoSmithKline has all but ruled out a sale of its consumer healthcare business in the next three years, disappointing...

  8. Fast FT

    February 3, 2016

    GSK profits suffers steep fall in 2015

    GlaxoSmithKline suffered a steep fall in profits in 2015 and there was no let up in the decline during the fourth...

  9. Fast FT

    February 3, 2016

    Opening Quote: Hargreaves shrugs off difficult markets

    Hargreaves Lansdown’s assets under management have risen to a record despite difficult markets for investors,...

  10. FT Alphaville

    February 3, 2016

    FT Opening Quote

    Hargreaves Lansdown’s assets under management have risen to a record despite difficult markets for investors, ChemChina...

  11. February 2, 2016

    GSK and Adaptimmune in $500m deal to develop T-cell cancer drug

    GlaxoSmithKline has expanded its alliance with Adaptimmune to accelerate development of a groundbreaking cancer drug in...

  12. Fast FT

    February 2, 2016

    Axovant plunges on Pfizer Alzheimer drug move

    Shares in Axovant, a small biotech pursuing the first approval for a new Alzheimer’s drug in over a decade, plunged 29...

  13. February 2, 2016

    J&J and GSK join Medicxi’s European life sciences push

    Johnson & Johnson and GlaxoSmithKline have teamed up behind a €210m venture capital fund to invest in European life...

  14. February 1, 2016

    Investor calls for big pharma to slim down grow louder

    Some of the world’s biggest pharmaceuticals groups are facing calls to break up their diversified businesses in favour...

  15. January 31, 2016

    Gilead risks becoming victim of its own success

    During the past two years, Gilead, a California-based drugmaker, has emerged as the undisputed leader of the four large...

  16. Fast FT

    January 27, 2016

    Novartis to streamline operations, misses estimates

    Novartis has announced plans to streamline its operations as a strong US dollar continued to weigh on its earnings. The...

  17. January 25, 2016

    The Zika virus — where did it come from and where will it end?

    Let’s start at the beginning. Where did Zika come from? Like so many emerging viruses, Zika came out of Africa. It was...

  18. January 25, 2016

    Global pharma groups reveal tie-up with universities

    Three of the world’s biggest pharmaceuticals groups have teamed up with a trio of Britain’s top universities to create...

  19. January 21, 2016

    GSK scientists accused of stealing cancer research secrets

    Two GlaxoSmithKline scientists are among five people charged by US federal prosecutors with stealing cancer research...

  20. January 21, 2016

    Drugmakers call for collective action on superbugs

    Most of the world’s biggest pharmaceuticals groups have backed a declaration committing the industry to help tackle...

  21. January 20, 2016

    GlaxoSmithKline and Qualcomm in talks over health tech tie-up

    GlaxoSmithKline and Qualcomm are in talks to set up a joint venture potentially worth up to $1bn to develop medical...

  22. January 12, 2016

    Pressure builds on GSK with US filing for generic Advair

    GlaxoSmithKline has moved a step closer to losing US market exclusivity on its best-selling asthma drug after Mylan...

  23. January 11, 2016

    Big pharma joins forces to tackle cancer

    Some of the biggest makers of cancer drugs are joining an alliance to speed up the discovery of new treatments for the...

  24. January 7, 2016

    GSK confident halting payments to doctors will pay off

    GlaxoSmithKline has become the first big drugmaker to stop paying doctors to promote its products in response to...

  25. January 3, 2016

    GSK and AstraZeneca prescribe different treatments

    For GlaxoSmithKline and AstraZeneca — twin pillars of Britain’s pharmaceuticals sector — 2016 promises to be a critical...

  26. January 3, 2016

    GSK chief fights back to regain investor faith

    GlaxoSmithKline’s embattled chief executive is preparing to launch a big push to reset investor perceptions of the...

  27. December 18, 2015

    Generics revive Philippines pharma industry

    The Philippines is a developing country in which nearly 70 per cent of healthcare spending goes to the private sector....

  28. December 18, 2015

    GSK spends up to $1.5bn on HIV drugs in BMS deal

    GlaxoSmithKline has agreed to buy the HIV assets of Bristol-Myers Squibb for up to $1.5bn in the latest sign of...

  29. Fast FT

    December 18, 2015

    GlaxoSmithKline in deal to bulk up HIV treatments

    There appears to be no end to the pharmaceuticals deals that are being pushed through before the end of the year. Today...

  30. December 16, 2015

    AstraZeneca pours millions into China R&D

    AstraZeneca is to invest hundreds of millions of dollars expanding its capacity to develop and manufacture drugs in...

  31. December 15, 2015

    Sanofi/Boehringer: swap shop

    Swapping assets was a form of human trade since long before bankers and their fees arrived on the scene. In...

  32. December 15, 2015

    Sanofi seeks to expand in consumer health with €18bn asset swap

    Sanofi has entered exclusive talks with Boehringer Ingelheim over an €18bn asset exchange that would see the French...

  33. December 15, 2015

    FDA performs U-turn over restriction of pain drug

    US regulators have taken the rare step of reversing a decision aimed at curbing the use of a pain medicine after the...

  34. December 6, 2015

    China healthcare: Missing a beat

    Not long after taking the helm of GlaxoSmithKline in 2008, Sir Andrew Witty visited Shanghai to deliver a message along...

  35. FT Alphaville

    December 4, 2015

    Relypsa: the next US biotech M&A target?

    StreetInsider.com reports: Merck & Co (NYSE: MRK) plans to make a non-binding offer to acquire Relypsa, (Nasdaq: RLYP),...

  36. November 26, 2015

    GlaxoSmithKline navigates difficult path in China after scandal

    When Hervé Gisserot was asked to ride to the rescue of GlaxoSmithKline’s crisis-hit Chinese operations in 2013, the job...

  37. November 26, 2015

    GSK confident of China renaissance

    GlaxoSmithKline has predicted a return to growth in China next year as it slowly begins to repair the damage from a...

  38. November 26, 2015

    Unhealthy drugs: Pharma struggles with its reputation

    An industry dedicated to saving and extending lives might be expected to find empathy easy. Instead, some of the...

Search for GlaxoSmithKline PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Sir Andrew Witty’s strategy for returning GlaxoSmithKline to ...
    May 11, 2015

    Sir Andrew Witty’s strategy for returning GlaxoSmithKli...

  2. Today’s top headlines from the FirstFT briefing...
    February 4, 2015

    Today’s top headlines from the FirstFT briefing

  3. Pharmaceuticals group announces cost cutting...
    October 22, 2014

    Pharmaceuticals group announces cost cutting